We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
OMLYCLO
Australian Public Assessment Report
Device/Product Name
OMLYCLO
Active ingredients
Omalizumab
AusPAR Date
Published
Submission Number
PM-2023-04803-1-5
Submission Type
New biosimilar
Decision
Approved